Table IV.
AML | ALL | CML | CLL | MDS | Total n (%) | |
---|---|---|---|---|---|---|
Patients, n (%) | 35 | 7 | 1 | 1 | 2 | 46 (84) |
Duration, months, mean (range) | 4.8 (0.5–12.6) | 9.4 (0.1–40) | 7.5 (7.5) | 3.6 (3.6) | 9.5 (1.1–17.8) | 5.4 (0.1–40) |
AML: acute myelogenous leukaemia; ALL: acute lymphoblastic leukaemia; CML: chronic myeloid leukaemia; CLL: chronic lymphocytic leukaemia; MDS: myelodysplastic syndrome.